Cutaneous T-Cell Lymphoma Mycosis Fungoides

Gloucester Pharmaceuticals Reports Positive Interim Phase II Data …PharmaLive.com (press release), PA - Jun 5, 2007The Company is conducting a pivotal phase II study of romidepsin for patients with cutaneous T-cell lymphoma (CTCL) and has initiated a pivotal phase II …

Read full story